Stepan Co: Form 10-Q for the period ended Sep 30, 2014
Filed with the SEC on Oct 29, 2014 and accepted by EDGAR at Oct 29, 2014, 10:16 ET.
Management's discussion and analysis
As filed, 63,520 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following is management’s discussion and analysis (MD&A) of certain significant factors that have affected the Company’s financial condition and results of operations during the interim period included in the accompanying condensed consolidated financial statements.
The matters discussed in the MD&A include forward-looking statements that are subject to certain risks, uncertainties and assumptions. Such forward-looking statements are intended to be identified in this document by the words, “anticipate,” “believe,” “estimate,” “expect,” “intend,” “may,” “objective,” “outlook,” “plan,” “project,” “possible,” “potential,” “should” and similar expressions. Actual results may vary materially.
Forward-looking statements speak only as of the date they are made, and the Company does not undertake any obligation to update them to reflect changes that occur after that date. Factors that could cause actual results to differ materially include the items described in Item 1A of the Company’s Annual Report on Form 10-K for the year ended December 31, 2013.
Overview
The Company produces and sells intermediate chemicals that are used in a wide variety of applications worldwide. The overall business comprises three reportable segments:
- Surfactants – Surfactants, which accounted for 67 percent of consolidated net sales in the first three quarters of 2014, are principal ingredients in consumer and industrial cleaning products such as detergents for washing clothes, dishes, carpets, floors and walls, as well as shampoos and body washes. Other applications include fabric softeners, germicidal quaternary compounds, lubricating ingredients, emulsifiers for spreading agricultural products and industrial applications such as latex systems, plastics and composites. Surfactants are manufactured at six North American sites (five in the U.S. and one in Canada), three European sites (United Kingdom, France and Germany), three Latin American sites (Mexico, Brazil and Colombia) and two Asian sites (Philippines and Singapore). The Company also holds a 50 percent ownership interest in a joint venture, TIORCO, LLC (TIORCO), that markets chemical solutions for increasing the production of crude oil and natural gas from existing fields (enhanced oil recovery or EOR). The joint venture is accounted for under the equity method, and its financial results are excluded from the Surfactants segment operating results. Sales and related profits of the Company’s surfactants to enhanced oil recovery customers are included in Surfactants segment results.
- Polymers – Polymers, which accounted for 29 percent of consolidated net sales in the first three quarters of 2014, include polyurethane polyols, polyester resins and phthalic anhydride. Polyurethane polyols are used in the manufacture of rigid foam for thermal insulation in the construction industry and are also a base raw material for coatings, adhesives, sealants and elastomers (collectively CASE products) and flexible foams. Polyester resins, which include liquid and powdered resins, are used in CASE and polyurethane systems house applications. Phthalic anhydride is used in unsaturated polyester resins, alkyd resins and plasticizers for applications in construction materials and components of automotive, boating and other consumer products. In addition, the Company uses phthalic anhydride internally in the production of polyols. In the U.S.,
polyurethane polyols and phthalic anhydride are manufactured at the Company’s Millsdale, Illinois, site and polyester resins are manufactured at the Company’s Columbus, Georgia, site. In Europe, polyols are manufactured at the Company’s subsidiaries in Germany and Poland. In Asia, polyols are currently toll produced for the Company’s 80-percent owned joint venture in Nanjing, China.
- Specialty Products – Specialty Products, which accounted for 4 percent of consolidated net sales in the first three quarters of 2014, include flavors, emulsifiers and solubilizers used in food, flavoring, nutritional supplement and pharmaceutical applications. Specialty Products are primarily manufactured at the Company’s Maywood, New Jersey, site and, in some instances, at outside contractors.
Deferred Compensation Plans
The accounting for the Company’s deferred compensation plans can cause period-to-period fluctuations in Company expenses and profits. Compensation expense results when the values of Company common stock and mutual fund investment assets held for the plans increase, and compensation income results when the values of Company common stock and mutual fund investment assets decline. The pretax effect of all deferred compensation-related activities (including realized and unrealized gains and losses on the mutual fund assets held to fund the deferred compensation obligations) and the income statement line items in which the effects of the activities were recorded are displayed in the following table:
(In millions)
| Income (Expense) For the Three Months Ended September 30 2014 | 2013 | Change | |
|---|---|---|---|
| Deferred Compensation (Administrative expense) | $4.1 | $(2.2) | $6.3 (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.2 | 1.1 | (0.9) |
| Investment Income (Other, net) | 0.1 | — | 0.1 |
| Pretax Income Effect | $4.4 | $(1.1) | $5.5 |
(In millions)
| Income (Expense) For the Nine Months Ended September 30 2014 | 2013 | Change | |
|---|---|---|---|
| Deferred Compensation (Administrative expense) | $9.8 | $(3.5) | $13.3 (1) |
| Realized/Unrealized Gains on Investments (Other, net) | 0.7 | 2.1 | (1.4) |
| Investment Income (Other, net) | 0.3 | 0.1 | 0.2 |
| Pretax Income Effect | $10.8 | $(1.3) | $12.1 |
(1) See the Corporate Expenses section of this MD&A for details regarding the quarter-over-quarter and year-over-year changes in deferred compensation expense.
Effects of Foreign Currency Translation
The Company’s foreign subsidiaries transact business and report financial results in the subsidiaries’ local currencies. As a result, foreign subsidiary income statements are translated into U.S. dollars at average foreign exchange rates appropriate for the reporting period. Because foreign exchange rates fluctuate against the U.S. dollar over time, foreign currency translation affects period-to-period comparisons of financial statement items (i.e., because foreign exchange rates fluctuate, similar period-to-period local currency results for a foreign subsidiary may translate into different U.S. dollar results). The following table presents the effects that foreign currency translation had on the period-over-period changes in consolidated net sales and various income line items for the three and nine month periods ended September 30, 2014:
(In millions)
| Three Months Ended September 30 2014 2013 | Increase (Decrease) | Increase (Decrease) Due to Foreign Translation | |
|---|---|---|---|
| Net Sales | $491.4 $475.5 | $15.9 | $1.2 |
| Gross Profit | 65.1 74.3 | (9.2) | (0.1) |
| Operating Income | 22.3 31.1 | (8.8) | (0.2) |
| Pretax Income | 18.2 27.8 | (9.6) | (0.2) |
| Nine Months Ended September 30 | Increase (Decrease) | ||
| (In millions) | 2014 2013 | Increase (Decrease) | Due to Foreign Translation |
| Net Sales | $1,473.0 $1,406.5 | $66.5 | $2.7 |
| Gross Profit | 199.7 220.7 | (21.0) | (0.2) |
| Operating Income | 81.7 95.2 | (13.5) | (0.3) |
| Pretax Income | 69.5 85.3 | (15.8) | (0.3) |
30
RESULTS OF OPERATIONS
Three Months Ended September 30, 2014 and 2013
Summary
Net income attributable to the Company for the third quarter of 2014 declined 34 percent quarter-over-quarter to $13.5 million, or $0.59 per diluted share, compared to $20.4 million, or $0.89 per diluted share, for the third quarter of 2013. Below is a summary discussion of the major factors leading to the quarter-over-quarter changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the third quarter of 2014 follows the summary.
Consolidated net sales increased $16.0 million, or three percent, quarter over quarter. Higher average selling prices and the effects of foreign currency translation favorably affected the net sales change by $35.0 million and $1.2 million, respectively. A four percent decline in sales volume negatively affected the change in net sales by $20.2 million. The increase in average selling prices was primarily attributable to higher quarter-over-quarter raw material costs for Surfactants. The Surfactants segment also accounted for the consolidated sales volume decrease. Surfactants sales volume declined eight percent largely due to reduced quarter-over-quarter volumes for North American operations. Sales volume for the Polymers segment increased eight percent due to solid growth in North America. Sales volume for Specialty Products was up five percent.
Operating income for the third quarter of 2014 declined $8.8 million, or 28 percent, from operating income reported for the same quarter of 2013. Gross profit declined $9.2 million, or 12 percent, mainly due to a 28 percent decrease in profit for Surfactants caused by lower sales volume and higher expenses for North American operations. Polymer 2014 third quarter gross profit increased six percent over 2013 third quarter gross profit despite $3.7 million of business interruption insurance recovery income that benefited the prior year. Specialty Products gross profit was also up between quarters.
Operating expenses declined $0.4 million, or one percent, between quarters. The following summarizes the quarter-over-quarter changes in the individual income statement line items that comprise the Company’s operating expenses:
- Selling expenses increased $3.9 million, or 30 percent, quarter over quarter primarily due to a $3.4 million bad debt charge necessitated when a major Polymer customer filed for bankruptcy in September 2014.
- Administrative expenses declined $3.2 million, or 18 percent, quarter over quarter largely due to decreases in deferred compensation ($6.3 million) and U.S. fringe benefit ($0.7 million) expenses. In addition, the prior year’s expenses included estimated dismantling costs for the Nanjing, China, manufacturing plant of $0.7 million that did not recur in 2014. Deferred compensation expenses declined due to a third quarter 2014 decline in the value of Company common stock compared to a third quarter 2013 increase (see the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details). Fringe benefit expense declined primarily as a result of lower quarter-over-quarter incentive-based compensation estimates.
The foregoing items were partially offset by a $4.3 million charge to increase the best estimate of the remediation liability for the Company’s Maywood, New Jersey, site. The U.S. Environmental Protection Agency issued its final record of decision for the site in September 2014, which led to the increase in the best estimate of the liability.
- Research, development and technical service (R&D) expenses declined $1.1 million, or nine percent, quarter over quarter. Approximately $0.8 million of the decrease reflected lower U.S. fringe benefit expenses, particularly for incentive-based compensation.
Net interest expense for the third quarter of 2014 declined $0.1 million, or five percent, from net interest expense for the third quarter of last year. The decrease reflected lower quarter-over-quarter average debt levels primarily resulting from scheduled debt repayments.
The loss from the Company’s 50-percent equity joint venture (TIORCO) declined $0.2 million quarter over quarter due to higher commission and technical service income.
Other, net was less than $0.1 million of expense for the third quarter of 2014 compared to $1.1 million of income for the third quarter of 2013. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets decreased $0.9 million between quarters to $0.2 million in the third quarter of 2014 from $1.1 million in the third quarter of 2013. Foreign exchange losses totaled $0.2 million for the third quarter of 2014 compared to $0.1 million for the same quarter a year ago.
The effective tax rate was 26.0 percent for the third quarter of 2014 compared to 27.6 percent for the third quarter of 2013. The decrease was primarily attributable to a larger percentage of consolidated income being generated outside the U.S. where the effective tax rates are generally lower and to an increased tax benefit realized from certain U.S. deductions as a percentage of consolidated income. These decreases were partially offset by the expiration of the U.S. research and development tax credit and the small agri-biodiesel producer tax credit.
Segment Results
(In thousands)
| Net Sales | For the Three Months Ended September 30, 2014 September 30, 2013 | Increase | Percent Change |
|---|---|---|---|
| Surfactants | $318,486 $318,357 | $129 | — |
| Polymers | 152,955 137,649 | 15,306 | +11 |
| Specialty Products | 19,988 19,460 | 528 | +3 |
| Total Net Sales | $491,429 $475,466 | $15,963 | +3 |
| (In thousands) | For the Three Months Ended | ||
| Operating Income | September 30, 2014 September 30, 2013 | Increase (Decrease) | Percent Change |
| Surfactants | $11,115 $24,094 | $(12,979) | -54 |
| Polymers | 18,268 19,076 | (808) | -4 |
| Specialty Products | 3,029 1,311 | 1,718 | +131 |
| Segment Operating Income | $32,412 $44,481 | $(12,069) | -27 |
| Corporate Expenses | 10,159 13,396 | (3,237) | -24 |
| Total Operating Income | $22,253 $31,085 | $(8,832) | -28 |
Surfactants
Surfactants net sales for the third quarter of 2014 increased $0.1 million, or less than one percent, over net sales for the third quarter of 2013. Higher average selling prices, due largely to higher raw material costs, and the effects of foreign currency translation had positive effects of $23.5 million and $0.6 million, respectively, on the quarter-over-quarter net sales change. An eight percent decline in sales volume negatively affected the net sales change by $24.0 million. A quarter-over-quarter comparison of net sales by region follows:
(In thousands)
| For the Three Months Ended September 30, 2014 | September 30, 2013 | Increase (Decrease) | Percent Change | |
|---|---|---|---|---|
| North America | $190,920 | $186,148 | $4,772 | +3 |
| Europe | 71,421 | 69,513 | 1,908 | +3 |
| Latin America | 41,364 | 41,241 | 123 | — |
| Asia | 14,781 | 21,455 | (6,674) | -31 |
| Total Surfactants Segment | $318,486 | $318,357 | $129 | — |
Net sales for North American operations increased three percent due to higher average selling prices that more than offset the effects of lower sales volume and foreign currency translation. The increased selling prices, which reflected higher raw material costs, had a $22.3 million favorable effect on the quarter-over-quarter net sales change. A nine percent decrease in sales volume and the effects of foreign currency translation negatively affected the quarter-over-quarter change in net sales by $16.8 million and $0.7 million, respectively. Decreased sales of products used in laundry and cleaning, personal care, and biodiesel applications accounted for the North American sales volume decline. These decreases in sales volumes were partially offset by sales volume growth for products used in oil field and household, industrial and institutional applications (HI&I). Sales to the Company’s smaller, fragmented customer base sold through its distributor partners were also higher. The declines in laundry and cleaning and personal care sales volumes were primarily attributable to customers bringing surfactant production in-house to more fully utilize their internal capacity. As in the first and second quarters of 2014, the Company chose not to sell and manufacture biodiesel products in the third quarter of 2014 because to do so would not have been economically advantageous.
Net sales for European operations increased three percent due to the effects of foreign currency translation and a one percent increase in sales volume, which accounted for $1.6 million and $0.5 million, respectively, of the quarter-over-quarter net sales growth. Selling prices were down less than one percent between quarters. A stronger British pound sterling versus the U.S. dollar led to the favorable translation impact. The increase in sales volume reflected higher demand for HI&I and laundry and cleaning products.
Net sales for Latin American operations increased less than one percent between quarters. The impact of a two percent increase in sales volume was largely offset by a one percent decline in average selling prices and by the effects of foreign currency translation. The sales volume increase was primarily attributable to the region’s operations in Brazil.
Net sales for Asian operations declined 31 percent due to a 29 percent decline in sales volume. Sales volume for the third quarter of 2013 included one-time shipments of low margin methyl ester products out of Singapore to customers in Asia and low margin trial products to Europe. Singapore sales volume of products to U.S. operations was up 21 percent.
Surfactants operating income for the third quarter of 2014 declined $13.0 million, or 54 percent, from operating income for the third quarter of 2013. Gross profit decreased $12.5 million principally due to lower profits for North American operations. Operating expenses increased $0.5 million, or two percent. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Three Months Ended September 30, 2014 | September 30, 2013 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $17,531 | $29,364 | $(11,833) | -40 |
| Europe | 5,752 | 5,149 | 603 | +12 |
| Latin America | 4,968 | 5,325 | (357) | -7 |
| Asia | 4,327 | 5,211 | (884) | -17 |
| Surfactants Segment Gross Profit | $32,578 | $45,049 | $(12,471) | -28 |
| Operating Expenses | 21,463 | 20,955 | 508 | +2 |
| Operating Income | $11,115 | $24,094 | $(12,979) | -54 |
North American gross profit declined 40 percent quarter over quarter. The decrease in profit was attributable to the effects of lower sales and production volumes and higher raw material costs and plant expenses. Despite a decline in production volume, manufacturing costs were up $2.0 million (six percent) quarter over quarter largely due to higher maintenance and depreciation expenses. The Company also incurred higher freight expenses due to increased general freight rates and a planned infrastructure upgrade project at its Anaheim, California, plant, which resulted in shifting production to other locations.
Gross profit for European operations increased 12 percent quarter over quarter due to increased sales volume and a more favorable mix of sales.
Gross profit for Latin American operations declined seven percent due to a less favorable mix of sales coupled with higher raw material costs that more than offset the increase in sales volume. The change in sales mix reflected lower agricultural chemical sales resulting from drought conditions in Brazil.
Gross profit for Asian operations declined 17 percent primarily due to the decline in sales volume.
Operating expenses for the Surfactants segment increased $0.5 million, or two percent, quarter over quarter. Operating expenses were up $0.8 million for Latin American operations primarily due to increased spending to support the Company’s growth initiative in Brazil. Lower North American operations fringe benefit expenses, largely the result of reduced estimates for incentive-based compensation, partially offset the increased costs in Latin America.
Polymers
Polymers net sales for the third quarter of 2014 increased $15.3 million, or 11 percent, over net sales for the third quarter of 2013. An eight percent increase in sales volume, higher selling prices and the effects of foreign currency translation accounted for $10.5 million, $4.2 million and $0.6 million, respectively, of the quarter-over-quarter net sales improvement. North American operations accounted for most of the improvement in net sales and sales volume. A quarter-over-quarter comparison of net sales by region follows:
(In thousands)
| For the Three Months Ended September 30, 2014 | September 30, 2013 | Increase (Decrease) | Percent Change | |
|---|---|---|---|---|
| North America | $99,702 | $84,096 | $15,606 | +19 |
| Europe | 46,767 | 45,981 | 786 | +2 |
| Asia and Other | 6,486 | 7,572 | (1,086) | -14 |
| Total Polymers Segment | $152,955 | $137,649 | $15,306 | +11 |
Net sales for North American operations increased 19 percent due to a 16 percent increase in sales volume and a two percent increase in average selling prices, which accounted for $13.4 million and $2.2 million, respectively, of the quarter-over-quarter net sales improvement. Sales volume of polyols used in rigid foam applications improved 21 percent, primarily due to an improving economy and the energy conservation benefits achieved from using more insulation. Sales volumes for specialty polyols increased 33 percent as the Company continued to pursue growth opportunities for polyester resin and other CASE products. Most of the specialty polyols volume growth was attributable to the 2013 BMS polyester resin acquisition. Phthalic anhydride sales volume increased 14 percent between quarters due to new business partially offset by lower sales to a large customer.
Net sales for European operations increased two percent due to an increase in selling prices ($0.8 million positive effect) and the favorable effects of foreign currency translation ($0.7 million positive effect) partially offset by a two percent decline in sales volume ($0.7 million negative effect). The selling price increases reflected higher raw material costs. Demand for the Company’s polyol products used in rigid insulation board and metal panels was down slightly between quarters due to geopolitical issues that have resulted in economic uncertainty in Europe. Sales volume for specialty polyols was up quarter over quarter.
Net sales for Asia and Other regions declined 14 percent quarter over quarter due to decreased sales volume. Currently the Company supplies its customers in China and other parts of Asia with product imported from other Company sites and from local manufacturers. This sourcing is expected to continue until a new plant in China is operational, which is currently projected to be in the first half of 2016.
Polymers operating income for the third quarter of 2014 declined $0.8 million, or four percent, from operating income for the same quarter of 2013. Current quarter income was negatively impacted by a $3.4 million bad debt charge resulting from the filing for bankruptcy by a large North American phthalic anhydride customer. In addition, last year’s quarter benefited from the receipt of a $3.7 million business interruption insurance recovery for lost business related to a 2011 fire that damaged equipment at the Germany plant site. Quarter-over-quarter comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Three Months Ended September 30, 2014 | September 30, 2013 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $22,422 | $15,875 | $6,547 | +41 |
| Europe | 5,286 | 10,411 | (5,125) | -49 |
| Asia and Other | 389 | 274 | 115 | +42 |
| Polymers Segment Gross Profit | $28,097 | $26,560 | $1,537 | +6 |
| Operating Expenses | 9,829 | 7,484 | 2,345 | +31 |
| Operating Income | $18,268 | $19,076 | $(808) | -4 |
Gross profit for North American operations increased 41 percent due to the 16 percent increase in sales volume and to the positive impact of lower cost orthoxylene (the raw material for phthalic anhydride) and a more favorable mix of product sales. The Company will be taking a planned three-week maintenance shutdown in October of 2014, which will unfavorably affect fourth quarter gross profit.
Gross profit for European operations declined 49 percent quarter over quarter. The decrease between quarters was largely attributable to the non-recurring 2013 benefit of $3.7 million of business interruption insurance income. The decrease in sales volume coupled with higher raw material costs also contributed to the decline in gross profit.
The increase in gross profit for Asia and Other regions was largely due to lower costs and a more favorable sales mix.
Operating expenses for the Polymers segment were up $2.3 million due to the $3.4 million bad debt charge for the large North American phthalic anhydride customer that that filed for bankruptcy protection. The effect of the bad debt charge was partially offset by a $0.7 million favorable quarter-over-quarter change attributable to non-recurring 2013 charges for estimated dismantling costs for the Nanjing, China, manufacturing plant and by lower 2014 North American fringe benefit expenses, largely the result of reduced estimates for incentive-based compensation.
Specialty Products
Net sales for the third quarter of 2014 increased $0.5 million, or three percent, over net sales for the third quarter of 2013. Increased sales volume of products used in flavoring and pharmaceutical applications accounted for the net sales improvement. Operating income increased $1.7 million due to higher sales volume, the timing of pharmaceutical orders and lower operating expenses.
Corporate Expenses
Corporate expenses, which comprise operating expenses that are not allocated to the reportable segments, declined $3.2 million to $10.2 million for the third quarter of 2014 from $13.4 million for the same quarter of 2013. The quarter-over-quarter decline in corporate expenses was primarily attributable to decreased deferred compensation ($6.3 million) and fringe benefit ($0.9 million) expenses partially offset by increased legal and environmental expenses ($4.0 million). The decrease in deferred compensation expense ($4.1 million of income for the third quarter of 2014 compared to $2.2 million of expense for the third quarter of 2013) reflected an $8.48 per share 2014 third quarter decline in the value of Company stock, to which a substantial portion of the deferred compensation obligation is tied, compared to a third quarter 2013 increase of $2.12 per share. The following table presents the quarter-end Company common stock prices used in the computation of deferred compensation expense:
| 2014 September 30 | June 30 | 2013 September 30 | June 30 | |
|---|---|---|---|---|
| Company Stock Price | $44.38 | $52.86 | $57.73 | $55.61 |
The decrease in fringe benefit expenses was principally attributable to lower estimates for 2014 incentive-based compensation.
The increase in legal and environmental expenses was due to a $4.3 million charge to increase the best estimate of the remediation liability for the Company’s Maywood site. The U.S. Environmental Protection Agency issued its final record of decision for the site in September 2014, which led to the increase in the best estimate of the remediation liability.
Nine Months Ended September 30, 2014 and 2013
Summary
Net income attributable to the Company for the first three quarters of 2014 declined 18 percent year-over-year to $50.9 million, or $2.22 per diluted share, compared to $62.2 million, or $2.71 per diluted share, for the first three quarters of 2013. Below is a summary discussion of the major factors leading to the year-over-year changes in net sales, profits and expenses. A detailed discussion of segment operating performance for the first three quarters of 2014 follows the summary.
Consolidated net sales increased $66.5 million, or five percent, between years. Higher average selling prices and the effects of foreign currency translation favorably affected the net sales change by $103.9 million and $2.7 million, respectively. A three percent decline in sales volume negatively affected the net sales change by $40.1 million. The increase in average selling prices was attributable to higher year-over-year raw material costs, primarily for Surfactants. The Surfactants segment also accounted for the consolidated sales volume decrease. Surfactants sales volume declined seven percent largely due to reduced volumes for North American operations. Sales volume for the Polymers segment increased 16 percent due to solid organic growth in North America and Europe and to the contribution of the North American polyester resins business acquired from Bayer MaterialScience LLC (BMS) in June 2013. Sales volume for Specialty Products declined one percent.
Operating income for the first three quarters of 2014 declined $13.6 million, or 14 percent, from operating income reported for the first three quarters of 2013. Gross profit decreased $21.0 million, or 10 percent, largely due to lower profits for Surfactants mainly driven by lower sales volume and higher expenses for operations in North America. Polymers gross profit was up 12 percent between years despite $3.7 million of business interruption insurance recovery income that benefited the prior year. Specialty Products reported a 13 percent year-over-year gross profit increase.
Operating expenses declined $7.5 million, or six percent, year over year. The following summarizes the year-over-year changes in the individual income statement line items that comprise the Company’s operating expenses:
- Selling expenses increased $3.4 million, or eight percent, year over year. The increase was primarily attributable to a $3.4 million bad debt charge necessitated when a major Polymer customer filed for bankruptcy protection in September 2014.
- Administrative expenses declined $10.6 million, or 22 percent, year over year primarily due to a $13.3 million reduction in deferred compensation expense and to a $1.1 million decrease in U.S. fringe benefits. A decrease in the value of Company stock for the first three quarters of 2014 compared to an increase in the value of Company common stock for the same period of last year led to the year-over-year decline in deferred compensation expense (see the ‘Overview’ and ‘Corporate Expenses’ sections of this MD&A for further details). The decline in fringe benefit expenses was largely attributable to a reduction in expenses for incentive-based compensation.
A $4.3 million charge to increase the best estimate of the remediation liability for the Company’s Maywood, New Jersey, site partially offset the impact of lower deferred compensation and fringe benefit expenses. The U.S. Environmental Protection Agency issued its final record of decision for the site in September 2014, which led to the increase in the best estimate of the remediation liability.
- R&D expenses declined $0.3 million, or one percent, year over year. Lower U.S. fringe benefit expenses ($1.4 million), partially offset by higher salary expenses ($0.6 million) and by the write-off of design and engineering costs for a lab upgrade capital project that the Company decided not to pursue ($0.4 million), accounted for most of the decline.
Net interest expense for the first three quarters of 2014 increased $1.3 million, or 18 percent, over net interest expense for the first three quarters of 2013. The increase reflected higher average debt levels arising from the $100.0 million private placement note purchase agreement the Company executed in June 2013. The Company borrowed the funds to finance the second quarter 2013 BMS North American polyester resins acquisition, other capital expenditures and general corporate purposes.
The loss from the Company’s 50-percent equity joint venture (TIORCO) declined $0.2 million year over year due to higher commission and technical service income, partially offset by higher operating expenses.
Other, net for the first three quarters of 2014 was $0.5 million of income compared to $1.6 million of income for the same period of 2013. Investment income (including realized and unrealized gains and losses) for the Company’s deferred compensation and supplemental defined contribution mutual fund assets declined $1.3 million between quarters to $1.0 million for the first three quarters of 2014 from $2.3 million for the first three quarters of 2013. Foreign exchange losses totaled $0.5 million for 2014 compared to $0.7 million for 2013.
The effective tax rate was 26.9 percent for the first three quarters of 2014 compared to 27.6 percent for the first three quarters of 2013. The decrease was primarily attributable to a greater percentage of consolidated income being generated outside the U.S. where the effective tax rates are generally lower. This decrease was partially offset by the expiration of the U.S. research and development tax credit and the small agri-biodiesel producer tax credit.
Segment Results
(In thousands)
| Net Sales | For the Nine Months Ended September 30, 2014 September 30, 2013 | Increase (Decrease) | Percent Change |
|---|---|---|---|
| Surfactants | $987,957 $989,417 | $(1,460) | — |
| Polymers | 420,332 354,972 | 65,360 | +18 |
| Specialty Products | 64,693 62,068 | 2,625 | +4 |
| Total Net Sales | $1,472,982 $1,406,457 | $66,525 | +5 |
| (In thousands) | For the Nine Months Ended | ||
| Operating Income | September 30, 2014 September 30, 2013 | Increase (Decrease) | Percent Change |
| Surfactants | $48,692 $79,712 | $(31,020) | -39 |
| Polymers | 47,538 43,364 | 4,174 | +10 |
| Specialty Products | 10,600 8,340 | 2,260 | +27 |
| Segment Operating Income | $106,830 $131,416 | $(24,586) | -19 |
| Corporate Expenses | 25,140 36,168 | (11,028) | -30 |
| Total Operating Income | $81,690 $95,248 | $(13,558) | -14 |
Surfactants
Surfactants net sales for the first three quarters of 2014 declined $1.5 million, or less than one percent, from net sales for the first three quarters of 2013. A seven percent drop in sales volume mainly attributable to North American operations and the effects of foreign currency translation accounted for $71.4 million and $1.8 million, respectively, of the net sales decline. An increase in average selling prices favorably affected the net sales change by $71.7 million. A year-over-year comparison of net sales by region follows:
(In thousands)
| For the Nine Months Ended September 30, 2014 | September 30, 2013 | Increase (Decrease) | Percent Change | |
|---|---|---|---|---|
| North America | $602,347 | $604,468 | $(2,121) | — |
| Europe | 219,533 | 216,062 | 3,471 | +2 |
| Latin America | 122,658 | 121,888 | 770 | +1 |
| Asia | 43,419 | 46,999 | (3,580) | -8 |
| Total Surfactants Segment | $987,957 | $989,417 | $(1,460) | — |
Net sales for North American operations declined less than one percent due to an 11 percent decrease in sales volume and the unfavorable effects of foreign currency translation, which accounted for $63.8 million and $3.0 million, respectively, of the decline in net sales. Decreased sales of products used in biodiesel, laundry and cleaning, personal care and agricultural chemical applications accounted for the North American sales volume decline. These sales volume decreases were partially offset by sales volume growth for products used in oil field and household, industrial and institutional applications and for surfactants sold through distributors. The Company chose not to manufacture and sell biodiesel products in the first three quarters of 2014 because to do so would not have been economically advantageous. The decline in laundry and cleaning and personal care sales volume was largely attributable to the severe winter weather that caused production issues at some Company and customer manufacturing facilities and to customers bringing surfactant production in-house to more fully utilize their internal capacity. The decline in agricultural chemical sales volume reflected lower customer demand resulting from a spring planting season that was shortened due to prolonged winter weather in parts of the U.S. Average selling prices increased 12 percent, which offset the effects of the sales volume decline and unfavorable foreign currency translation by $64.7 million. Higher year-over-year raw material costs led to the higher average selling prices.
Net sales for European operations increased two percent due to a $9.8 million favorable effect of foreign currency translation. Both the European euro and British pound sterling strengthened against the U.S. dollar year over year. Sales volume declined three percent, which offset the impact of currency translation by $5.6 million. A less than one percent decrease in average selling prices had a $0.7 million negative effect on the year-over-year change in net sales. The decline in sales volume reflected lower demand for laundry and cleaning and personal care products as well as some lost business resulting from competitive pricing situations. Sales volumes for functional surfactants, primarily agricultural and emulsion polymers and foamers products, were up year over year.
Net sales for Latin American operations increased one percent due to a five percent increase in average selling prices and a one percent increase in sales volume, which accounted for $5.7 million and $1.7 million, respectively, of the year-over-year net sales change. Higher raw material costs led to the increase in average selling prices. The year-over-year sales volume increase was tempered by decreased agricultural chemical sales due to drought conditions in Brazil. The effects of foreign currency translation negatively affected the change in net sales by $6.6 million. The foreign currency translation effect resulted from the year-over-year weakening of the Brazilian real and the Colombian and Mexican pesos against the U.S. dollar.
Net sales for Asian operations declined eight percent due to a 10 percent decline in sales volume and to a $2.1 million unfavorable foreign currency effect. Sales volume for the third quarter of 2013 included one-time shipments of low margin methyl ester products out of Singapore to customers in Asia and Europe that did not recur in 2014. Singapore sales volume of products to U.S. operations was up 110 percent, and sales volume for operations in the Philippines improved four percent.
Surfactants operating income for the first three quarters of 2014 declined $31.0 million, or 39 percent, from operating income for the same period of 2013. Gross profit decreased $30.8 million largely due to lower sales volume and higher expenses in North America. Foreign currency translation contributed $0.9 million to the gross profit decline. Operating expenses increased $0.2 million, or less than one percent. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Nine Months Ended September 30, 2014 | September 30, 2013 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $65,861 | $102,299 | $(36,438) | -36 |
| Europe | 20,112 | 18,581 | 1,531 | +8 |
| Latin America | 15,010 | 17,215 | (2,205) | -13 |
| Asia | 13,249 | 6,932 | 6,317 | +91 |
| Surfactants Segment Gross Profit | $114,232 | $145,027 | $(30,795) | -21 |
| Operating Expenses | 65,540 | 65,315 | 225 | — |
| Operating Income | $48,692 | $79,712 | $(31,020) | -39 |
North American gross profit declined 36 percent due to reduced sales volume and higher expenses. Manufacturing costs were up $8.2 million year over year largely due to increased maintenance, depreciation and utility costs. A major portion of the maintenance and utility cost increases was attributable to the prolonged inclement winter weather. In the first quarter of 2014, the Company incurred additional transportation expenses for the transfer of some production from weather-affected locations to other less impacted North American plants. Transportation expenses continued to be higher in the second and third quarters due to increased general freight rates and a planned infrastructure upgrade project at the Company’s Anaheim, California, plant. In addition to the foregoing, the Company recognized $1.8 million of accelerated depreciation in the first half of the current year related to the North American operations restructuring plan approved in the fourth quarter of 2013, which called for the shutdown of the Canadian sulfonation operation. All accelerated depreciation in connection with the restructuring for the Company’s Canadian sulfonation operation has been recognized.
Gross profit for European operations increased eight percent year over year. A more favorable mix of sales, lower material costs and a $0.7 million favorable foreign currency translation effect more than offset the impact of a three percent decline in sales volume.
Gross profit for Latin American operations declined 13 percent due to a less favorable mix of sales, higher raw material costs and an unfavorable $1.0 million foreign currency translation impact that more than offset the effect of a one percent increase in sales volume.
The year-over-year increase in gross profit for Asian operations was driven by the 110 percent increase in sales volume of methyl esters from Singapore to U.S. operations.
Operating expenses for the Surfactants segment increased $0.2 million, or less than one percent, between years. Operating expenses were up $1.3 million for Latin American operations primarily due to increased spending to support the Company’s growing organization in Brazil and to a first quarter 2014 increase in Colombia’s bad debt provision for a high-risk customer. Lower North American operations fringe benefit expenses, largely the result of reduced estimates for incentive-based compensation, partially offset the increased costs in Latin America.
Polymers
Polymers net sales for the first three quarters of 2014 increased $65.4 million, or 18 percent, over net sales for the first three quarters of 2013. A 16 percent increase in sales volume, the effects of foreign currency translation and higher average selling prices accounted for $57.4 million, $4.1 million and $3.9 million, respectively, of the year-over-year net sales improvement. The increase in sales volume was attributable to solid growth for North American and European operations. A year-over-year comparison of net sales by region follows:
(In thousands)
| For the Nine Months Ended September 30, 2014 | September 30, 2013 | Increase | Percent Change | |
|---|---|---|---|---|
| North America | $267,409 | $218,689 | $48,720 | +22 |
| Europe | 134,548 | 118,573 | 15,975 | +13 |
| Asia and Other | 18,375 | 17,710 | 665 | +4 |
| Total Polymers Segment | $420,332 | $354,972 | $65,360 | +18 |
Net sales for North American operations increased 22 percent due to a 20 percent increase in sales volume. Specialty polyols, which includes the polyester resin business acquired from BMS in June 2013, accounted for about 56 percent of the sales volume increase (the current year includes nine months of sales related to the acquisition from BMS compared to four months of sales in 2013). Sales volume for polyols used in rigid foam applications improved 16 percent, principally due to increased insulation usage to conserve energy and to an improved economy. Sales volume of phthalic anhydride was essentially unchanged between years. The impact of reduced business with a large phthalic anhydride was largely offset by new business.
Net sales for European operations increased 13 percent due to a 13 percent increase in sales volume and to the effects of foreign currency translation, which accounted for $15.2 million and $4.4 million, respectively, of the net sales improvement. Strong demand continued for the Company’s polyol products used in rigid insulation board and metal panels, particularly for the first half of 2014. Average selling prices declined three percent, which reduced the year-over-year net sales improvement by $3.6 million.
Net sales for Asia and Other regions increased four percent between years. Higher average selling prices due to a more favorable sales mix more than offset the effects of a seven percent sales volume decline. The sales mix reflected a year-over-year sales volume decrease in Asia and an increase in polymers sold in Latin America.
Polymers operating income for the first three quarters of 2014 increased $4.2 million, or 10 percent, over operating income for the same period of 2013. The 2014 gowth was tempered by a $3.4 million bad debt charge resulting from the filing for bankruptcy by a large North American phthalic anhydride customer. In addition, results for 2013 included the receipt of a $3.7 million business interruption insurance recovery. Year-over-year comparisons of gross profit by region and total segment operating expenses and operating income follow:
(In thousands)
| Gross Profit | For the Nine Months Ended September 30, 2014 | September 30, 2013 | Increase (Decrease) | Percent Change |
|---|---|---|---|---|
| North America | $51,629 | $42,256 | $9,373 | +22 |
| Europe | 17,601 | 20,807 | (3,206) | -15 |
| Asia and Other | 1,288 | (12) | 1,300 | NM |
| Polymers Segment Gross Profit | $70,518 | $63,051 | $7,467 | +12 |
| Operating Expenses | 22,980 | 19,687 | 3,293 | +17 |
| Operating Income | $47,538 | $43,364 | $4,174 | +10 |
Gross profit for North American operations increased 22 percent due to the 20 percent increase in sales volume. Specialty polyols, which includes the polyester resin business acquired from BMS in June 2013, accounted for 44 percent of the year-over-year gross profit improvement, as nine months of the new polyester resin activity were included in the 2014 financial results compared to four months in the 2013 results. As noted earlier, the Company will be taking a planned three-week maintenance shutdown in October of 2014, which will unfavorably impact fourth quarter profits.
Gross profit for European operations declined 15 percent year over year. The decrease was mainly attributable to the non-recurring 2013 benefit of $3.7 million of business interruption insurance income.
The increase in gross profit for Asia and Other regions was primarily due to $0.6 million of accelerated depreciation charged in the first half of 2013 that did not recur in 2014. The accelerated depreciation reflected the winding down of manufacturing operations at the Company’s Nanjing, China, plant. Higher selling prices and a more favorable mix of sales also contributed to the gross profit improvement between years.
Operating expenses for the Polymers segment were up $3.3 million, or 17 percent, between years due to the $3.4 million bad debt charge discussed earlier. The effect of the bad debt charge was partially offset by a $0.7 million favorable year-over-year change attributable to non-recurring 2013 charges for estimated dismantling costs for the Nanjing, China, manufacturing plant. Foreign currency translation unfavorably affected the year-over-year change in operating expenses by $0.2 million.
Specialty Products
Net sales for the first three quarters of 2014 increased $2.6 million, or four percent, over net sales for the first three quarters of 2013. Selling price increases for food ingredient and nutritional supplement products more than offset the effect of a one percent sales volume decline. Operating income increased $2.3 million, or 27 percent, principally due to higher selling prices and lower operating expenses.
Corporate Expenses
Corporate expenses declined $11.1 million to $25.1 million for the first three quarters of 2014 from $36.2 million for the same period of 2013. The decline in corporate expenses was primarily due to decreased deferred compensation ($13.3 million) and fringe benefit ($1.7 million) expenses partially offset by increased legal and environmental expenses ($4.5 million). The decrease in deferred compensation expense ($9.8 million of income for the first three quarters of 2014 compared to $3.5 million of expense for the first three quarters of 2013) reflected a $21.25 per share decline in the value of Company stock for 2014 compared to an increase of $2.19 per share for 2013. The following table presents the quarter-end Company common stock prices used in the computation of deferred compensation expense:
| 2014 September 30 | 2013 December 31 | September 30 | 2012 December 31 | |
|---|---|---|---|---|
| Company Stock Price | $44.38 | $65.63 | $57.73 | $55.54 |
The decrease in fringe benefit expenses was principally attributable to lower estimates for 2014 incentive-based compensation.
The increase in legal and environmental expenses was due to a $4.3 million charge to increase the best estimate of the remediation liability for the Company’s Maywood site.
LIQUIDITY AND CAPITAL RESOURCES
For the nine months ended September 30, 2014, operating activities were a cash source of $44.9 million versus a source of $81.7 million for the comparable period in 2013. For the current year period, investing cash outflows totaled $67.3 million and financing activities consumed $19.6 million. Cash decreased by $44.6 million with exchange rates decreasing cash by $2.6 million.
For the current year-to-date, net income was down by $10.9 million and working capital consumed $20.7 million more than for the comparable year-ago period. Cash outflows for investing activities were down by $72.5 million year over year. Cash flow for financing activities was a use of $19.6 million in 2014 compared to a source of $86.3 million in 2013.
For the current year-to-date, accounts receivable were a use of $31.0 million compared to a use of $41.1 million for the comparable period in 2013. Inventories were a use of $28.3 million in 2014 versus a use of $9.6 million in 2013. Accounts payable and accrued liabilities were a source of $8.4 million in 2014 compared to a source of $26.6 million for the same period in 2013.
Working capital requirements were higher during the first nine months of 2014, compared to the same period in 2013 due mainly to a larger increase in inventory quantities year over year combined with rising raw material costs in 2014 versus falling raw material costs in 2013. The Company’s working capital investment is heavily influenced by the cost of crude oil and natural oils, from which many of its raw materials are derived. Fluctuations in raw material costs translate directly to inventory carrying costs and indirectly to customer selling prices and accounts receivable.
The year-to-date accounts receivable increase was driven mainly by higher selling prices, partially offset by improved accounts receivable turnover since year-end. The year-to-date inventory cash use was driven mainly by higher quantities to support customer service levels for the U.S. The Company has not changed its own payment practices related to its payables. It is management’s opinion that the Company’s liquidity is sufficient to provide for potential increases in working capital during 2014.
Investing cash outflows for the current year-to-date included capital expenditures of $62.4 million compared to $67.1 million for the comparable period last year. Prior year investing outflows also included $68.2 million for the acquisition of the North American polyester resins business of BMS. Other investing activities consumed $4.9 million in 2014 versus $4.6 million in 2013.
For 2014, the Company estimates that capital expenditures will range from $100 million to $110 million including capacity expansions in China, Brazil, and the United States.
The Company purchases its common shares in the open market from time to time to fund its own benefit plans and also to mitigate the dilutive effect of new shares issued under its benefit plans. The Company may also make open market repurchases as cash flows permit. For the nine months ended September 30, 2014, the Company purchased 124,667 shares in the open market at a total cost of $6.6 million. At September 30, 2014, there were 833,645 shares remaining under the current share repurchase authorization.
As of September 30, 2014, the Company’s cash and cash equivalents totaled $88.7 million, including $8.2 million in two separate U.S. money market funds, each of which was rated AAA by Standard and Poor’s and Aaa by Moody’s. Cash in U.S. demand deposit accounts totaled $15.1 million and cash of the Company’s non-U.S. subsidiaries held outside the U.S. totaled $65.4 million at September 30, 2014.
Consolidated balance sheet debt decreased by $5.4 million for the current year-to-date, from $270.6 million to $265.2 million. Since last year-end, domestic debt decreased by $4.3 million and foreign debt decreased by $1.1 million. Net debt (which is defined as total debt minus cash) increased by $39.2 million for the current year-to-date, from $137.3 million to $176.5 million. As of September 30, 2014, the ratio of total debt to total debt plus shareholders’ equity was 31.6 percent compared to 32.8 percent at December 31, 2013. As of September 30, 2014, the ratio of net debt to net debt plus shareholders’ equity was 23.5 percent compared to 19.9 percent at December 31, 2013.
At September 30, 2014, the Company’s debt included $237.9 million of unsecured private placement loans with maturities extending from 2014 through 2025. These loans are the Company’s primary source of long-term debt financing and are supplemented by bank credit facilities to meet short and medium-term needs.
On July 10, 2014, the Company amended the committed $125.0 million multi-currency five-year revolving credit agreement with JPMorgan Chase Bank, N.A., as administrative agent, and four U.S. banks named as lenders thereunder. The credit agreement allows the Company to make unsecured borrowings, as requested from time to time, for working capital and other corporate purposes. The amendment extends the maturity date of the 2012 Agreement from September 20, 2017 to July 10, 2019. This unsecured facility is the Company’s primary source of short-term borrowings with terms and conditions that are substantially equivalent to those of the Company’s other U.S. loan agreements. As of September 30, 2014, the Company had outstanding letters of credit of $3.0 million under the credit agreement and no borrowings, with $122.0 million remaining available. The Company anticipates that cash from operations, committed credit facilities and cash on hand will be sufficient to fund anticipated capital expenditures, working capital, dividends and other planned financial commitments for the foreseeable future.
Certain foreign subsidiaries of the Company maintain term loans and short-term bank lines of credit in their respective local currencies to meet working capital requirements as well as to fund capital expenditure programs and acquisitions. At September 30, 2014, the Company’s European subsidiaries had bank term loans of $3.5 million with maturities through 2016 and short-term bank debt of $23.4 million with remaining short-term borrowing capacity of $11.2 million. The Company’s Latin American subsidiaries had no short-term bank debt with $15.4 million of unused short-term borrowing capacity. The Company’s Philippine subsidiary had $0.4 million of short-term bank loans, which were guaranteed by the Company, with $7.6 million of unused borrowing capacity. The Company’s majority-owned joint venture in China had no short-term bank debt, with unused borrowing capacity of $6.5 million, on bank credit lines guaranteed by the Company.
The Company has material debt agreements that require the maintenance of minimum interest coverage and minimum net worth. These agreements also limit the incurrence of additional debt as well as the payment of dividends and repurchase of treasury shares. Testing for these agreements is based on the combined financial statements of the U.S. operations of the Company, Stepan Canada Inc., Stepan Quimica Ltda., Stepan Specialty Products, LLC, Stepan Specialty Products B.V. and Stepan Asia Pte. Ltd. (the “Restricted Group”). Under the most restrictive of these debt covenants:
1. The Restricted Group must maintain a minimum interest coverage ratio, as defined within the agreements, of 2.0 to 1.0, for the preceding four calendar quarters.
2. The Restricted Group must maintain net worth of at least $325.0 million.
3. The Restricted Group must maintain a ratio of long-term debt to total capitalization, as defined in the agreements, not to exceed 55 percent.
4. The Restricted Group may pay dividends and purchase treasury shares after December 31, 2013, in amounts of up to $100.0 million plus 100 percent of net income and cash proceeds of stock option exercises, measured cumulatively after June 30, 2014. The maximum amount of dividends that could have been paid within this limitation is disclosed as unrestricted retained earnings in Note 12, Debt, in the Notes to Consolidated Financial Statements.
The Company believes it was in compliance with all of its loan agreements as of September 30, 2014. Based on current projections, the Company believes it will be in compliance with its loan agreements throughout 2014.
ENVIRONMENTAL AND LEGAL MATTERS
The Company is subject to extensive federal, state and local environmental laws and regulations. Although the Company’s environmental policies and practices are designed to ensure compliance with these laws and regulations, future developments and increasingly stringent environmental regulation could require the Company to make additional unforeseen environmental expenditures. The Company will continue to invest in the equipment and facilities necessary to comply with existing and future regulations. During the first nine months of 2014 and 2013, the Company’s expenditures for capital projects related to the environment were $6.0 million and $3.4 million, respectively. These projects are capitalized and depreciated over their estimated useful lives, which are typically 10 years. Recurring costs associated with the operation and maintenance of facilities for waste treatment and disposal and managing environmental compliance in ongoing operations at the Company’s manufacturing locations were $15.8 million and $13.8 million for the nine months ended September 30, 2014 and 2013, respectively. While difficult to project, it is not anticipated that these recurring expenses will increase significantly in the future.
Over the years, the Company has received requests for information related to or has been named by the government as a potentially responsible party at a number of waste disposal sites where cleanup costs have been or may be incurred under CERCLA and similar state statutes. In addition, damages are being claimed against the Company in general liability actions for alleged personal injury or property damage in the case of some disposal and plant sites. The Company believes that it has made adequate provisions for the costs it may incur with respect to the sites. It is the Company’s accounting policy to record liabilities when environmental assessments and/or remedial efforts are probable and the cost or range of possible costs can be reasonably estimated. When no amount within the range is a better estimate than any other amount, the minimum is accrued. Some of the factors on which the Company bases its estimates include information provided by feasibility studies, potentially responsible party negotiations and the development of remedial action plans. After partial remediation payments at certain sites, the Company has estimated a range of possible environmental and legal losses of $19.1 million to $29.0 million at September 30, 2014, compared to $9.7 million to $28.9 million at December 31, 2013. At September 30, 2014, and December 31, 2013, the Company’s accrued liability for such losses, which represented the Company’s best estimate within the estimated range of possible environmental and legal losses, was $19.2 million and $14.7 million, respectively. The increase in the environmental and legal liability was primarily attributable to a $4.3 million increase in the best estimate to remediate the Company’s Maywood, New Jersey site. See Item 1, Part 2, Legal Proceedings, in this report and Note 7 to the condensed consolidated financial statements for further information. During the first nine months of 2014, cash outlays related to legal and environmental matters approximated $0.8 million compared to $1.8 million for the same period in 2013.
For certain sites, the Company has responded to information requests made by federal, state or local government agencies but has received no response confirming or denying the Company’s stated positions. As such, estimates of the total costs, or range of possible costs, of remediation, if any, or the Company’s share of such costs, if any, cannot be determined with respect to these sites. Consequently, the Company is unable to predict the effect thereof on the Company’s financial position, cash flows and results of operations. Given the information available, management believes the Company has no liability at these sites. However, in the event of one or more adverse determinations with respect to such sites in any annual or interim period, the effect on the Company’s cash flows and results of operations for those periods could be material. Based upon the Company’s present knowledge with respect to its involvement at these sites, the possibility of other viable entities’ responsibilities for cleanup, and the extended period over which any costs would be incurred, the Company believes that these matters, individually and in the aggregate, will not have a material effect on the Company’s financial position. Certain of these matters are discussed in Item 1, Part 2, Legal Proceedings, in this report and in other filings of the Company with the Securities and Exchange Commission, which are available upon request from the Company. See also Note 7 to the condensed consolidated financial statements for a summary of the environmental proceedings related to certain environmental sites.
OUTLOOK
Stepan Company’s fourth quarter results will continue to be negatively impacted by lower commodity surfactant volumes in North America. Alternatives to improve returns on commodity assets are being pursued. Polymer growth typically slows in the fourth quarter, and this year’s results will include approximately $1 million in expenses associated with a planned maintenance shutdown of the Company’s Phthalic Anhydride production unit.
The Company has experienced a difficult 2014. Management recognizes that the Company’s performance has been disappointing, but there are many projects underway which are expected to reduce costs and aggressively build sales. The Company looks forward to improving Surfactant volumes and product mix and continuing to build on the momentum within its Polymer segment.
CRITICAL ACCOUNTING POLICIES
There have been no changes to the critical accounting policies disclosed in the Company’s 2013 Annual Report on Form 10-K.
Controls and procedures
As filed, 733 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
a. Evaluation of Disclosure Controls and Procedures
Based on their evaluation of our disclosure controls and procedures as of the end of the most recent fiscal quarter covered by this Form 10-Q, our Chief Executive Officer and our Chief Financial Officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934) were effective as of September 30, 2014.
b. Changes in Internal Control Over Financial Reporting
There were no changes in internal controls that occurred during our most recent fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-07-01 to 2014-09-30 | $491.4m | us-gaap:SalesRevenueNet |
| Revenue | 9 months2014-01-01 to 2014-09-30 | $1.47bn | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months2014-07-01 to 2014-09-30 | $426.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 9 months2014-01-01 to 2014-09-30 | $1.27bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2014-07-01 to 2014-09-30 | $65.1m | us-gaap:GrossProfit |
| Gross profit | 9 months2014-01-01 to 2014-09-30 | $199.7m | us-gaap:GrossProfit |
| Operating income | 3 months2014-07-01 to 2014-09-30 | $22.3m | us-gaap:OperatingIncomeLoss |
| Operating income | 9 months2014-01-01 to 2014-09-30 | $81.7m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2014-07-01 to 2014-09-30 | $2.8m | us-gaap:InterestExpense |
| Interest expense | 9 months2014-01-01 to 2014-09-30 | $8.8m | us-gaap:InterestExpense |
| Income tax | 3 months2014-07-01 to 2014-09-30 | $4.7m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 9 months2014-01-01 to 2014-09-30 | $18.7m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-07-01 to 2014-09-30 | $13.5m | us-gaap:NetIncomeLoss |
| Net income | 9 months2014-01-01 to 2014-09-30 | $50.9m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-07-01 to 2014-09-30 | $0.59 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 9 months2014-01-01 to 2014-09-30 | $2.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-07-01 to 2014-09-30 | $0.59 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 9 months2014-01-01 to 2014-09-30 | $2.24 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2014-07-01 to 2014-09-30 | 22,875,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 9 months2014-01-01 to 2014-09-30 | 22,923,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 9 months2014-01-01 to 2014-09-30 | $44.9m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 9 months2014-01-01 to 2014-09-30 | $62.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 9 months2014-01-01 to 2014-09-30 | $11.4m | us-gaap:PaymentsOfDividends |
| Share repurchases | 9 months2014-01-01 to 2014-09-30 | $6.6m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2014-09-30 | $88.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-09-30 | $609.0m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-09-30 | $1.18bn | us-gaap:Assets |
| Current liabilities | At period end2014-09-30 | $272.3m | us-gaap:LiabilitiesCurrent |
| Long-term debt | At period end2014-09-30 | $228.8m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2014-09-30 | $36.4m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2014-09-30 | $574.4m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001193125-14-386406. Last ingested by Listed: Nov 10, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.